Dingal, Prince Jay P.
HRN: 21-39-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
MUPIROCIN 2%, 15G (TUBE)
05/28/2023
06/04/2023
TOPICAL
1g
TID
Cellulitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes